| scholarly article | Q13442814 |
| P2093 | author name string | M. Shawkat Razzaque | |
| P2860 | cites work | Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 | Q24290481 |
| Cellular signaling by fibroblast growth factor receptors | Q24301087 | ||
| Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein | Q24309454 | ||
| The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis | Q24625902 | ||
| FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? | Q24653541 | ||
| Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis | Q24671728 | ||
| Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members | Q24683254 | ||
| A potential link between phosphate and aging--lessons from Klotho-deficient mice | Q27687316 | ||
| Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain | Q28141252 | ||
| FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization | Q28177435 | ||
| Klotho converts canonical FGF receptor into a specific receptor for FGF23 | Q28272505 | ||
| FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis | Q28289695 | ||
| Regulation of fibroblast growth factor-23 signaling by klotho | Q28587100 | ||
| Intestinal npt2b plays a major role in phosphate absorption and homeostasis | Q33561684 | ||
| In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels | Q33572351 | ||
| Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation | Q33591785 | ||
| New insights into the pathogenesis of inherited phosphate wasting disorders. | Q33697498 | ||
| FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. | Q34017992 | ||
| Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging | Q34072221 | ||
| Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule | Q34072230 | ||
| Disease model: human aging | Q34207950 | ||
| Vitamin D deficiency and risk of cardiovascular disease | Q34586829 | ||
| Klotho: a fundamental regulator of aging | Q34936976 | ||
| The dualistic role of vitamin D in vascular calcifications | Q35059753 | ||
| Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase | Q35126790 | ||
| Injury by hypertonic phosphate enema | Q35815849 | ||
| A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis | Q35925637 | ||
| Structural basis for fibroblast growth factor receptor activation | Q36111391 | ||
| Regulation of phosphorus homeostasis by the type iia na/phosphate cotransporter | Q36191092 | ||
| Structural and biochemical properties of fibroblast growth factor 23. | Q36216956 | ||
| Hypophosphatemia: an update on its etiology and treatment | Q36272304 | ||
| Phosphate diabetes, tubular phosphate reabsorption and phosphatonins | Q36281188 | ||
| Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17 | Q36288869 | ||
| Bone disease in idiopathic hypercalciuria | Q36507240 | ||
| Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism | Q36507256 | ||
| Hyperphosphataemia and Hypocalcaemia Induced by Hypertonic Phosphate Enema - An Experimental Study and Review of the Literature | Q36533759 | ||
| The kidney and bone metabolism: Nephrologists' point of view. | Q36638034 | ||
| Premature aging in klotho mutant mice: cause or consequence? | Q36757962 | ||
| The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis | Q36860289 | ||
| FGFR3 and FGFR4 do not mediate renal effects of FGF23. | Q36985772 | ||
| High dietary inorganic phosphate increases lung tumorigenesis and alters Akt signaling | Q37041944 | ||
| In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis | Q37072412 | ||
| The discovery of alpha-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis | Q37251753 | ||
| Role of microtubules in the rapid regulation of renal phosphate transport in response to acute alterations in dietary phosphate content | Q37365202 | ||
| Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model | Q37415834 | ||
| Amelioration of the premature ageing-like features of Fgf-23 knockout mice by genetically restoring the systemic actions of FGF-23 | Q37418420 | ||
| Phosphate homeostasis and the renal-gastrointestinal axis | Q37763810 | ||
| An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. | Q40482177 | ||
| Hypocalcemic coma following two pediatric phosphate enemas. | Q40880768 | ||
| Cellular/molecular control of renal Na/Pi-cotransport | Q41743339 | ||
| Therapeutic potential of klotho-FGF23 fusion polypeptides: WO2009095372 | Q42529430 | ||
| Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process | Q42736434 | ||
| Does FGF23 toxicity influence the outcome of chronic kidney disease? | Q43078080 | ||
| Brain damage following a hypertonic phosphate enema | Q43997107 | ||
| Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population | Q44059496 | ||
| Severe hyperphosphatemia and hypocalcemia following the rectal administration of a phosphate-containing Fleet pediatric enema | Q44962321 | ||
| High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients | Q44977753 | ||
| Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype | Q46264351 | ||
| Cola beverage consumption induces bone mineralization reduction in ovariectomized rats | Q46289583 | ||
| Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23. | Q46631798 | ||
| DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. | Q54943458 | ||
| Prolonged increase in dietary phosphate intake alters bone mineralization in adult male rats☆ | Q56089663 | ||
| Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice | Q56767950 | ||
| Inorganic Phosphate Is Transported into Mitochondria in the Absence of ATP Biosynthesis: Anin Vivo31P NMR Study in the Human Skeletal Muscle | Q57203483 | ||
| A phosphorus-31 NMR study of mitochondrial inorganic phosphate visibility: effects of calcium(2+) and manganese(2+) and the pH gradient | Q67748023 | ||
| Fatal poisoning from sodium phosphate enema. Case report and experimental study | Q68967880 | ||
| Fluid and Serum Electrolyte Disturbances as a Complication of Enemas in Hirschsprung's Disease | Q72055251 | ||
| Consumption of soft drinks with phosphoric acid as a risk factor for the development of hypocalcemia in postmenopausal women | Q73064988 | ||
| Regulation of small intestinal Na-P(i) type IIb cotransporter by dietary phosphate intake | Q73070911 | ||
| Molecular targets of hyperphosphataemia in chronic renal failure | Q73444971 | ||
| A fatal small dose of phosphate enema in a young child with no renal or gastrointestinal abnormality | Q73498176 | ||
| Fatal hyperphosphatemia after oral phosphate overdose in a premature infant | Q73851838 | ||
| Acute effects of soft drink intake on calcium and phosphate metabolism in immature and adult rats | Q77382389 | ||
| Parathyroid hormone and dietary phosphate provoke a lysosomal routing of the proximal tubular Na/Pi-cotransporter type II | Q77394418 | ||
| Severe hyperphosphatemia and hypocalcemic tetany after oral laxative administration in a 3-month-old infant | Q79136886 | ||
| FGF-23, vitamin D and calcification: the unholy triad | Q80394650 | ||
| Toward a better understanding of Klotho | Q83283214 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 91-97 | |
| P577 | publication date | 2011-02-01 | |
| P1433 | published in | Clinical Science | Q372419 |
| P1476 | title | Phosphate toxicity: new insights into an old problem | |
| P478 | volume | 120 |
| Q47126125 | A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway |
| Q64933982 | A comparison of lithium-substituted phosphate and borate bioactive glasses for mineralised tissue repair. |
| Q40896471 | Antialbuminuric actions of calcilytics in the remnant kidney |
| Q33986838 | Calpain 1 inhibitor BDA-410 ameliorates α-klotho-deficiency phenotypes resembling human aging-related syndromes |
| Q37244863 | Can features of phosphate toxicity appear in normophosphatemia? |
| Q37498019 | Can salivary phosphate levels be an early biomarker to monitor the evolvement of obesity? |
| Q53065423 | Correlation of interleukin-17-producing effector memory T cells and CD4+CD25+Foxp3 regulatory T cells with the phosphate levels in chronic hemodialysis patients. |
| Q35003219 | Dietary and genetic evidence for enhancing glucose metabolism and reducing obesity by inhibiting klotho functions |
| Q64231827 | Dysregulated Phosphate Metabolism, Periodontal Disease, and Cancer: Possible Global Health Implications |
| Q28085476 | Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity |
| Q35107527 | Effect of nickel on nutrient removal by selected indigenous protozoan species in wastewater systems |
| Q47118083 | Exploiting parameter space in MOFs: a 20-fold enhancement of phosphate-ester hydrolysis with UiO-66-NH2 † †Electronic supplementary information (ESI) available. See DOI: 10.1039/c4sc03613a Click here for additional data file |
| Q47193934 | Exploiting parameter space in MOFs: a 20-fold enhancement of phosphate-ester hydrolysis with UiO-66-NH2. |
| Q43074642 | FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6. |
| Q36992835 | Genetic induction of phosphate toxicity significantly reduces the survival of hypercholesterolemic obese mice |
| Q51422415 | Glycerophosphate does not interact with components of parenteral nutrition. |
| Q61810543 | Higher Intra-Dialysis Serum Phosphorus Reduction Ratio as a Predictor of Mortality in Patients on Long-Term Hemodialysis |
| Q46313956 | Hyperphosphatemia induces senescence in human endothelial cells by increasing endothelin-1 production. |
| Q36003122 | Hyperphosphatemia, Phosphoprotein Phosphatases, and Microparticle Release in Vascular Endothelial Cells. |
| Q90721090 | In Vivo Toxicity and In Vitro Solubility Assessment of Pre-Treated Struvite as A Potential Alternative Phosphorus Source in Animal Feed |
| Q28535055 | Inadequate awareness among chronic kidney disease patients regarding food and drinks containing artificially added phosphate |
| Q99725135 | Inorganic Phosphate (Pi) Signaling in Endothelial Cells: A Molecular Basis for Generation of Endothelial Microvesicles in Uraemic Cardiovascular Disease |
| Q34119083 | Lack of awareness among future medical professionals about the risk of consuming hidden phosphate-containing processed food and drinks |
| Q60921741 | Magnesium: Are We Consuming Enough? |
| Q35059924 | Molecular regulation of phosphate metabolism by fibroblast growth factor-23-klotho system |
| Q35059741 | Osteo-renal regulation of systemic phosphate metabolism |
| Q35025454 | Osteocalcin: a pivotal mediator or an innocent bystander in energy metabolism? |
| Q58797979 | Phosphate control in reducing FGF23 levels in hemodialysis patients |
| Q51323466 | Phosphate toxicity: a stealth biochemical stress factor? |
| Q55284883 | Phosphate-dependent FGF23 secretion is modulated by PiT2/Slc20a2. |
| Q37179265 | Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients. |
| Q45833383 | Reciprocal regulation of calcium-/phosphate-regulating hormones in cyclists during the Giro d'Italia 3-week stage race. |
| Q91458078 | Role of phosphate sensing in bone and mineral metabolism |
| Q90324505 | Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease |
| Q64118860 | The CSD Drug Subset: The Changing Chemistry and Crystallography of Small Molecule Pharmaceuticals |
| Q49282725 | The age-related changes of dietary phosphate responsiveness in plasma 1,25-dihydroxyvitamin D levels and renal Cyp27b1 and Cyp24a1 gene expression is associated with renal α-Klotho gene expression in mice |
| Q35059753 | The dualistic role of vitamin D in vascular calcifications |
| Q36992839 | The role of Klotho in energy metabolism |
| Q34337575 | The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease |
| Q45991431 | Urinary metabolic signatures and early triage of acute radiation exposure in rat model. |
| Q38633152 | Vitamin D, phosphate, and vasculotoxicity. |
Search more.